Nightingale Health Plc
Company release
24 April 2023 at 5:10 p.m. (EEST)

The Extraordinary General Meeting of Nightingale Health Plc was held on 24 April 2023. The meeting was held as a fully virtual remote meeting in accordance with Chapter 5, Section 16, Subsection 3 of the Finnish Companies Act.

Board of Directors

The number of members of the Board of Directors was confirmed to be six (6). Antti Kangas, Olli Karhi, Leena Niemistö, Timo Soininen ja Teemu Suna were re-elected as members of the Board of Directors and Ilkka Laurila was elected as a new member of the Board of Directors for a term that expires at the end of the next Annual General Meeting.

Publication of the minutes

The minutes of the Extraordinary General Meeting will be available on the company’s website on 8 May 2023 at the latest.

Resolutions of the Board of Directors of Nightingale Health Plc

In the organizational meeting held after the Extraordinary General Meeting, the Board of Directors elected Leena Niemistö as chair from among its members.


For further information:
CEO Teemu Suna,

Certified Adviser:

Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale Health

Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it’s also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.